Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regulus Therapeutics

3.30
-0.1950-5.59%
Volume:1.71M
Turnover:5.77M
Market Cap:218.27M
PE:-4.00
High:3.60
Open:3.51
Low:3.24
Close:3.49
Loading ...
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Apr 13, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2023

Major Issues Report

8-K - Current report
Feb 01, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 06, 2023

Major Issues Report

8-K - Current report
Dec 12, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 15, 2022

Major Issues Report

8-K - Current report
Jun 27, 2022

Major Issues Report

8-K - Current report
Jun 13, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals